Pharmacy Clinical Prior Authorization Assistance Chart Effective February 2018

Similar documents
PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

Texas Vendor Drug Program. Formulary Drug Index File Layout. Layout effective: Jul. 2, 2018 Document update: Oct. 1, 2018

Texas Vendor Drug Program. Formulary Delimited File Layout. April 26, 2017

Fentanyl Agents Clinical Edit Criteria

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

METABOLIC, IMMUNE DISORDERS OR INHERITED RARE DISEASE ALPHA-1 PROTEINASE INHIBITORS ARANESP BLOOD CELL DEFICIENCY ARANESP ARCALYST

TRICARE Uniform Formulary. Pre-Authorization Requirements

RAHF PFM ALPHANINE SD COAGULATION FACTOR IX J7193 COAGULATION FACTOR IX (RFIXFC)

Exclusion Reasons Presumption of Long- Term Non-Acute Administration C9399 Unclassified Drugs or

ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017

PHARMACY AND THERAPEUTICS COMMITTEE 4 th Quarter 2017

Step Therapy Approval Criteria

Duragesic patch. Duragesic patch (fentanyl patch) Description

Michigan Department of Community Health Quantity Limitations

Oregon Health Plan prescription benefit updates

2018 BCN Advantage Prior Authorization Criteria Last updated: November, 2017

2018 BCN Advantage Prior Authorization Criteria Last updated: April, 2018

Movantik (naloxegol), Relistor (methylnaltrexone bromide), Symproic (naldemedine)

Step Therapy Criteria

Texas Association of Rural Health Clinics Annual Education Conference

Quarterly pharmacy formulary change notice

ADHD STIMULANTS - SCORE

STAT Bulletin. Drug Therapy Guideline Updates. To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT MAY 29, 2012

Prescription Drug Benefit Rider V

Step Therapy Approval Criteria

Secretary for Health and Family Services Selections for Preferred Products

ADHD STIMULANTS - SCORE

STAT Bulletin. Drug Therapy Guideline Updates. To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business

Embeda. Embeda (morphine sulfate and naltrexone hydrochloride) Description

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Golden State Medicare Health Plan, Golden (HMO) Last Updated: 09/01/2018

CYTOKINE AND CAM ANTAGONIST UTILIZATION IN MISSISSIPPI MEDICAID

BRINTELLIX. Step Therapy Criteria HealthTeam Advantage Formulary ID: Version 6 Effective Date: 1/1/2016. PRODUCT(s) AFFECTED BRINTELLIX

ARISTADA. Products Affected Step 2: ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1.

Aetna Better Health. Specialty Drug Program

Michigan Department of Health & Human Services Quantity Limitations

Pharmacy and Medical Guideline Updates

THIRD QUARTER 2017 UPDATE CHANGES TO THE HIGHMARK DRUG FORMULARIES

Prescription Drug Benefit Rider

August 10, 2017 DURB Meeting Summary

Quarterly pharmacy formulary change notice

North Dakota Medicaid Therapeutic Duplication Edits

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Optima Tier Gold Formulary Date Effective: November 1, 2018.

Michigan Department of Health & Human Services Quantity Limitations

STEP THERAPY ALGORITHMS PUP Select Formulary

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Health Choice Generations 1 Tier Gold Effective Date: 11/01/2018.

UPMC for You Pharmacy and Therapeutics Committee Meeting July 27, 2010 meeting

1, 2014 PHARMACY BENEFIT

Morphine Sulfate Hydromorphone Oxymorphone

DIFICID. Products Affected Step 2: DIFICID TABLET 200 MG ORAL. Details

These programs and quantity limitations may not apply. Check your certificate or other plan information for benefit details.

Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18

: Opioid Quantity Limits

Transmucosal Immediate Release Fentanyl (TIRF) Prior Authorization, (Through Generic), and Quantity Limit Program Summary

Quarterly pharmacy formulary change notice

ALBUTEROL - SCORE{XE "ALBUTEROL - SCORE"}

Regulatory Status FDA-approved indication: Orencia is a selective T cell costimulation modulator indicated for: (1)

MEDICAL ASSISTANCE BULLETIN

Pharmacy Services Request Types

NATL. II. Health Net Approved Indications and Usage Guidelines: Diagnosis of cancer AND. Member is on fentanyl transdermal patches AND

See Important Reminder at the end of this policy for important regulatory and legal information.

LIMITED DISTRIBUTION MEDICATIONS

Limitations of use: Subsys may be dispensed only to patients enrolled in the TIRF REMS Access program (1).

Texas Vendor Drug Program. Pharmacy Provider Procedure Manual. Vitamin and Mineral Products. Effective Date. November 2017

Michigan Department of Community Health Co-pay and Quantity Limitations

Formulary Changes. One mission: you TABLE A. FORMULARY CHANGES 7/1/2018: Commercial 3-Tier Formulary. Commercial 4-Tier Formulary

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Farm Bureau Health Plans Date Effective: November 1, 2018.

SELF-ADMINISTERED MEDICATIONS LIST

Supplementary Online Content

ALOGLIPTIN STEP. Details. Step Therapy Requirements Effective November 1, 2017

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Regulatory Status FDA-approved indication: Orencia is a selective T cell costimulation modulator indicated for: (1)

Reason for change. Recently approved. Recently approved. Recently approved. Recently approved. Recently updated. Recently approved.

Alabama Medicaid Preferred Drug and Prior Authorization Program

Pulmonary Hypertension Weight Loss Skin Conditions. Skin Conditions Multiple Sclerosis Endocrine Disorder. Endocrine Disorder.

2009 Workers' Compensation Drug Trend Report. An analysis of trend and a forecast for the future

Nucynta IR/ Nucynta ER (tapentadol immediate-release and extendedrelease)

Aetna Better Health Illinois Premier Plan. November 2015 Formulary Updates. October 2015 Formulary Updates

Step Therapy Criteria

See Important Reminder at the end of this policy for important regulatory and legal information.

Capital BlueCross Open/Closed Formulary Update (1 st Quarter 2017)

Magellan Rx. A smarter approach to pharmacy benefits management

MedStar Medicare Choice Pharmacy Services

Medication trends shaping workers compensation. A 2018 mid-year review of the prevailing industry influences impacting pharmacy outcomes

Biologic Immunomodulators Prior Authorization with Quantity Limit Program Summary

Movantik (naloxegol), Relistor (methylnaltrexone bromide)

Therapeutic Class Indications Effective

Quarterly pharmacy formulary change notice

Regulatory Status FDA approved indication: Kineret is an interleukin-1 receptor antagonist indicated for: (1)

STEP THERAPY CRITERIA

THIRD QUARTER 2017 UPDATE CHANGES TO THE HIGHMARK DRUG FORMULARIES

PAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose

Movantik (naloxegol), Relistor (methylnaltrexone bromide), Symproic (naldemedine)

Step Therapy Criteria

Quarterly pharmacy formulary change

Transcription:

About Pharmacy Clinical Prior Authorizations Clinical prior authorizations (PA) are based on evidence-based clinical criteria and nationally recognized peer-reviewed information. The PA may apply to an individual drug or a drug class on the formulary, including some preferred and non-preferred drugs. Clinical PAs approved by the Texas Drug Utilization Review Board are available for use by the Vendor Drug Program (VDP) for traditional Medicaid (or fee-for-service, FFS) and by managed care organizations (MCO). There are certain clinical PAs that all MCOs are required to perform. Usage of all other clinical PA will vary between MCO at the discretion of each MCO. FFS: txvendordrug.com/formulary/prior-authorization/ffs-clinical-pa MCO: txvendordrug.com/formulary/prior-authorization/mco-clinical-pa Obtaining Prior Authorization for Medicaid Managed Care Prescribing providers or their representatives must contact the MCO. Call center phone numbers vary by MCO, and the Prescriber MCO Assistance Chart identifies prior authorization and member call center phone numbers for each MCO. txvendordrug.com/sites/txvendordrug/files/docs/managed-care/prescriber-assistancechart.pdf About the CPA Assistance Chart Each prior authorization guide includes a description of how the prior authorization requests are evaluated. All these steps apply to FFS Medicaid claims processed by VDP. This assistance chart identifies which prior authorizations are utilized by each MCO and how those prior authorizations relate to those used by VDP. VDP AET AGP BCS CMC HLT CFT CHC CKC DEL DRC EPF FCR MHT PRK SCW SND SUP TXC UHC Abbreviations Vendor Drug Program / FFS Aetna Amerigroup Blue Cross Blue Shield Children's Medical Center Cigna HealthSpring Community First Community Health Choice Cook Children's Dell Children's Health Plan Driscoll Children's El Paso First Premier FirstCare Molina Healthcare of Texas Parkland Scott & White Sendero Superior HealthPlan Texas Children's United Healthcare Symbol Definition Follows all steps of the prior authorization Does not follows all steps of the prior authorization Prior authorization does not apply Rev. 02/2018 mco-pcpaac TxVendorDrug.com PAGE 1 OF 7

February 2018 Revisions Added Dupixent Added Diclofenac Gel & Topical Solution Removed methylnatrexone bromide (Relistor) due to combination with other GI motility agents Brand Names Included Within Categories Prior Authorization Aliskiren Agents Cystic Fibrosis Cytokine and CAM Agonists Gaucher s Disease Gastrointestinal (GI) Motility Fentanyl Agents Hereditary Angioedema Injectable Pulmonary Hypertension Agents Leukotreine Modifiers Topical Immunomodulators Drugs Tekamlo, Tekturna, Tekturna HCT Kalydeco, Orkambi* Actemra, Cimzia, Ilaris, Kineret, Orencia, Simponi, Stelara, Xeljanz Cerezyme, Elelyso, Vpriv, Zavesca Amitiza, Linzess, Lotronex, Movantik, Relistor Abstral, Lazanda, Subsys, Actiq, Duragesic, Fentora Cinryze, Firazyr Flolan, Remodulin, Veletri Singulair (montelukast), Acccolate (zafirlukast), Zyflo (zileuton) Elidel, Protopic, Eucrisa Rev. 02/2018 mco-pcpaac TxVendorDrug.com PAGE 2 OF 7

Prior Authorization Information ADDADHD Medications Alinia (Nitazoxanide) Aliskiren-Containing Agents Allergen Extracts - Grastek/Oralair/Ragwitek Altabax (Retapamulin) Androgenic agents Antiemetics Antipsychotics* Anxiolytics and Sedatives/Hypnotics Byetta (Exenatide Injection) Carisoprodol Colcrys Contraceptives for CHIP clients Copaxone (Glatiramer) Cough/Cold Medications COX-2 Inhibitors Cymbalta Cystic Fibrosis (incl. Orkambi*) Cytokine and CAM Antagonists Rev. 02/2018 mco-pcpaac TxVendorDrug.com PAGE 3 OF 7

Desmopressin Dextromethorphan Overutilization Diabetic Test Strips Diclofenac Gel & Topical Solution Drug Regimen Optimization Dupixent Duplicate Therapy Emflaza Enzymes Erythropoiesis- Stimulating Agents Flexeril/Amrix (Cyclobenzaprine) Fentanyl Agents Forteo (Teriparatide) Fosrenol (Lanthanum) Gaucher s Disease Agents GI Motility Agents Growth Hormones H.P. Acthar Hepatitis C Virus (Initial)* Hepatitis C Virus (Refill)* Hereditary Angioedema Agents Rev. 02/2018 mco-pcpaac TxVendorDrug.com PAGE 4 OF 7

Imiquimod (Aldara/Zyclara) Increlex (Mecasermin) Inj. Pulmonary Hypertension Agents Ketorolac (Toradol) Leukotriene Modifiers Lidocaine Patches Lovaza Capsules Lyrica Makena Nuedexta Neurontin (Gabapentin) Nuplazid Opiate Overutilization Opiate/Benzo/Muscle Relaxant Combinations OxyContin (Oxycodone) PCSK9 Inhibitors Phenergan/Phenergan Containing Products* Plavix Propylthiouracil Provigil (Modafinil) Ranexa Revatio (Sildenafil) Rev. 02/2018 mco-pcpaac TxVendorDrug.com PAGE 5 OF 7

Savella Sitagliptin (Januvia) Suboxone/Subutex Symlin (Pramlintide Acetate) Synagis (Palivizumab) Thiazolidinediones Topical Acne Agents (Non Retinoid) Topical Immunomodulators Tyvaso Starter Kit (CHIP) Victoza (Liraglutide) Solution for Injection Xenical (Orlistat) Xenazine Xifaxan (Rifaximin) Xyrem Zelboraf Rev. 02/2018 mco-pcpaac TxVendorDrug.com PAGE 6 OF 7

Some MCOs have a preferred brand of glucose monitoring test strips as shown below. If no brand is listed, the prescriber may choose any brand on VDP formulary. MCO AET AGP BCS CMC HLT CFT CHC CKC DEL DRC EPF FCR MHT PRK SCW SND SUP TXC UHC Preferred Product Name OneTouch TRUETEST and TRUE METRIX TEST STRIPS - Nipro Freestyle, Truetuest, Precision Xtra, Truetrack Nipro and Abbott (Freestyle and Precision). TRUE METRIX - Nipro OneTouch Rev. 02/2018 mco-pcpaac TxVendorDrug.com PAGE 7 OF 7